ATE191923T1 - Interleukine-6 mutante mit verbesserter biologischer aktivität im vergleich zu wildtyp il-6 - Google Patents

Interleukine-6 mutante mit verbesserter biologischer aktivität im vergleich zu wildtyp il-6

Info

Publication number
ATE191923T1
ATE191923T1 AT94900984T AT94900984T ATE191923T1 AT E191923 T1 ATE191923 T1 AT E191923T1 AT 94900984 T AT94900984 T AT 94900984T AT 94900984 T AT94900984 T AT 94900984T AT E191923 T1 ATE191923 T1 AT E191923T1
Authority
AT
Austria
Prior art keywords
wild
mutant
type
biological activity
interleukine
Prior art date
Application number
AT94900984T
Other languages
English (en)
Inventor
Gennaro Ciliberto
Rocco Savino
Original Assignee
Angeletti P Ist Richerche Bio
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Angeletti P Ist Richerche Bio filed Critical Angeletti P Ist Richerche Bio
Application granted granted Critical
Publication of ATE191923T1 publication Critical patent/ATE191923T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52Cytokines; Lymphokines; Interferons
    • C07K14/54Interleukins [IL]
    • C07K14/5412IL-6
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00Peptide or protein sequence
    • Y10S930/01Peptide or protein sequence
    • Y10S930/14Lymphokine; related peptides
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00Peptide or protein sequence
    • Y10S930/01Peptide or protein sequence
    • Y10S930/14Lymphokine; related peptides
    • Y10S930/141Interleukin
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00Peptide or protein sequence
    • Y10S930/01Peptide or protein sequence
    • Y10S930/14Lymphokine; related peptides
    • Y10S930/142Interferon

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
AT94900984T 1992-11-06 1993-11-02 Interleukine-6 mutante mit verbesserter biologischer aktivität im vergleich zu wildtyp il-6 ATE191923T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ITRM920809A IT1263022B (it) 1992-11-06 1992-11-06 Interleuchina-6 mutante con attivita' biologica migliorata rispetto all'interleuchina-6 selvatica.
PCT/IT1993/000114 WO1994011402A1 (en) 1992-11-06 1993-11-02 Mutant interleukin 6 with improved biological activity over wild interleukin 6

Publications (1)

Publication Number Publication Date
ATE191923T1 true ATE191923T1 (de) 2000-05-15

Family

ID=11401276

Family Applications (1)

Application Number Title Priority Date Filing Date
AT94900984T ATE191923T1 (de) 1992-11-06 1993-11-02 Interleukine-6 mutante mit verbesserter biologischer aktivität im vergleich zu wildtyp il-6

Country Status (12)

Country Link
US (1) US5681723A (de)
EP (1) EP0667872B1 (de)
JP (1) JP2515491B2 (de)
AT (1) ATE191923T1 (de)
CA (1) CA2129824C (de)
DE (1) DE69328437T2 (de)
DK (1) DK0667872T3 (de)
ES (1) ES2145819T3 (de)
GR (1) GR3033685T3 (de)
IT (1) IT1263022B (de)
PT (1) PT667872E (de)
WO (1) WO1994011402A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1274782B (it) * 1994-12-14 1997-07-24 Angeletti P Ist Richerche Bio Metodo per selezionare superagonisti, antagonisti e superantagonisti di ormoni del cui complesso recettoriale fa parte gp 130
IT1277926B1 (it) * 1995-09-01 1997-11-12 Angeletti P Ist Richerche Bio Uso di muteine di citochine naturali come immunogeni per la preparazione di composizioni farmaceutiche per curare o prevenire
AU6961796A (en) * 1995-09-12 1997-04-01 Chiron Corporation Improved interleukin-6 receptor antagonist
AU7078200A (en) * 1999-08-27 2001-03-26 United States Of America, Represented By The Secretary, Department Of Health And Human Services, The Polypeptides, comprising il-6 ligand-binding receptor domains and related nucleic acids, antibodies, compositions, and methods of use
IL161673A0 (en) 2004-04-29 2004-09-27 Applied Research Systems Compositions and methods for therapy of chemotherapy-induced neuropathy
EP2832856A4 (de) 2012-03-29 2016-01-27 Chugai Pharmaceutical Co Ltd Anti-lamp5-antikörper und verwendung davon
CN113698467A (zh) * 2020-05-19 2021-11-26 甘李药业股份有限公司 Il-6变体及其用途
WO2022256688A1 (en) 2021-06-04 2022-12-08 Sonnet BioTherapeutics, Inc. Methods of treating age-related frailty with interleukin-6

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUT52962A (en) * 1988-03-04 1990-09-28 Sandoz Ag Process for production of medical compositions eliminating bone-absorption and promoting forming of bones
US5210075A (en) * 1990-02-16 1993-05-11 Tanabe Seiyaku Co., Ltd. Interleukin 6 antagonist peptides

Also Published As

Publication number Publication date
IT1263022B (it) 1996-07-23
WO1994011402A1 (en) 1994-05-26
JP2515491B2 (ja) 1996-07-10
EP0667872A1 (de) 1995-08-23
ITRM920809A1 (it) 1994-05-06
JPH07501947A (ja) 1995-03-02
CA2129824C (en) 1997-03-04
DK0667872T3 (da) 2000-09-18
DE69328437T2 (de) 2000-11-02
US5681723A (en) 1997-10-28
EP0667872B1 (de) 2000-04-19
ES2145819T3 (es) 2000-07-16
GR3033685T3 (en) 2000-10-31
DE69328437D1 (de) 2000-05-25
PT667872E (pt) 2000-08-31
CA2129824A1 (en) 1994-05-26
ITRM920809A0 (it) 1992-11-06

Similar Documents

Publication Publication Date Title
ES2162132T3 (es) Polimerasa de adn termoestable procedente de thermoanaerobacter thermohydrosulfuricus y enzimas mutantes, de actividad exonucleasa suprimida asi obtenidos.
DE69435049D1 (de) Chimäre proteine zur vermeidung der komplementaktivierung
DE69635452D1 (de) Hohe expressionsrate des grün-fluoreszierenden proteins
DE69112207D1 (en) "walk-through"-mutagenese.
DE69535147D1 (de) Überexpression von säugetier- und virusproteinen
MY102806A (en) Human interleukin-3 and muteins thereof
DE69941701D1 (de) Mutanten von flt3-l und ihre verwendungen
DE69534468D1 (de) Wachstums-differenzierungsfaktor-11
MY102472A (en) Preparation of funtional human urokinase proteins.
UA27035C2 (uk) Кристал білка, зшитого багатофуhкціоhальhим зшивальним агеhтом (варіаhти), пристрій, що містить кристал білка та спосіб отримаhhя аспартаму
ES2151607T3 (es) Factor 12 de crecimiento y de diferenciacion.
SE8902532L (sv) Bestaemning av plasmaproteiner
FI954220A0 (fi) Yhdistelmä-mersasidiini ja sen valmistusmenetelmä
DE69328437D1 (de) Interleukine-6 Mutante mit verbesserter biologischer Aktivität im vergleich zu wildtyp IL-6
DK1200561T3 (da) Rekombinant stabil celleklon, dens fremstilling og anvendelse
ATE264913T1 (de) Protease-resistente analoge des thrombomodulin
DK0592566T3 (da) IL-6-muteiner med reduceret cysteinantal
SE9201966D0 (sv) Interleukin-1beta deletion mutant
DE58908428D1 (de) Sekretormutante von Escherichia coli.
DK1431391T3 (da) RANTES-mutanter og terapeutiske anvendelser heraf
ATE209252T1 (de) Rekombinante d-hydantoinase, verfahren zur herstellung und verwendung
EP0330700A4 (de) Menschlicher Prourokinase ähnliches Polypeptid.
MY104405A (en) Structural gene comprising dna coding for an endotoxin protein having toxic activity against insects.
DK0757994T3 (da) TCF-mutanter
EP0285361A3 (de) Reinigung von Apase-1 und Wiedererlangung des Nematodenresistenzgens

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee